The company was established in 1995, and the shareholding system reform was carried out at the end of 2007. At present, the listing materials have been submitted to the CSRC and are expected to be listed on the Shenzhen Stock Exchange in one or two years.
Our company is a high-tech enterprise integrating R&D, production and sales. The company's R&D and production are divided into four categories: electronic sphygmomanometer, blood glucose meter, low-frequency products and ECG monitoring.
The 1995 KD-322 electronic sphygmomanometer independently developed by the company is the first in China and has obtained the certified public accountant certificate recognized by the state. In 2000, it passed the ISO900 1 international quality system certification. At present, 123 products have been certified by EU CE, 27 products have been certified by US FDA, and 2 sphygmomanometers have been certified by British Hypertension Association BHS. The company owns 3 1 independent intellectual property patents, and 40 patents are being applied.
In 2008, the company's total production and sales of electronic sphygmomanometer ranked fifth in the world. Products are exported to more than 50 countries, and only Germany has a market share of 50%. It broke the monopoly of Japanese and Taiwan Province manufacturers on the electronic sphygmomanometer industry and became the only mainland enterprise in China that could compete with it.
Technology R&D: In 2007, the company's technology center was awarded as Tianjin Enterprise Technology Center.
In 2008, the company was continuously recognized as a high-tech enterprise in Tianjin.
The company has nearly 100 technical research and development personnel, and the research and development directions are divided into four categories: electronic sphygmomanometer, blood glucose meter, low-frequency products and ECG monitoring. All products have mastered the core technology and independent intellectual property rights.
This technical project spans many physiological parameter monitoring fields such as blood pressure data monitoring, blood sugar data monitoring, body temperature data monitoring, cardiovascular system monitoring, and medical care fields such as pulse, laser, infrared, heating and bioelectricity.
Production line: The company has 6 production lines of electronic sphygmomanometer, with a daily output of 20,000 sets, a monthly production capacity of 500,000 sets and an annual production capacity of 6 million sets.
In order to adapt to the development of international and domestic markets and further increase the international market share, especially to open the American market, the company has further improved various internal management systems and system documents in accordance with the provisions of QSR820 of the United States, making the company's management more standardized, standardized and internationalized.
Use steps of Jiuan blood glucose meter: